01/12/2015 18:16:33 Cookie Policy Free Membership Login

Antisoma Share Chat - ASM

Share Name Share Symbol Market Type Share ISIN Share Description
Antisoma LSE:ASM London Ordinary Share GB0055696032 ORD 1P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00 +0.00% 1.33 0.00 0.00 - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.8 0.6 0.1 13.3 8.47

Antisoma Share Discussion Threads

Showing 10576 to 10596 of 10600 messages
Post New Message
Chat Pages: 424  423  422  421  420  419  418  417  416  415  414  413  >>
Unlikely considering its changing purpose to an investment company!fenners66
What a sorry state of affairs. 2006 -2007 went from 12 p to 60p on possible good medical results. Antisoma tried real hard to crack the cancer blight, real pity it failed. At least they really had a good go at it. OXB 5p to 50p same,wife of ceo sold her total holding at 54p after that I never went back in. There is a huge failure list but I did believe in the possible good outcome of quite a few of these research stocks, as like so many of us we have lost loved ones to this terrible disease We live in hope. ASM might just develop a game changer yet.minho
Antisoma PLC is proposing to change its name to Sarossa Capital PLC.palwing13
Summit Tel: +44 (0)1235 443 951 Glyn Edwards / Richard Pye +44 (0)7825 313 476 Cairn Financial Advisers Same guy? Edwards I mean. I held these a few years back, got out at a loss, somewhat higher than this!rayrac
There's life yet.hTTp://www.an ADVFN competitor.com/action/news/showArticle?id=4678801palwing13
Do keep up Watson!jsbach123
Another small cap pharma biotech in trouble Only 1 in 10 make it to profitability picking the ones that do or might ain't easy Taken me 5 yearsbuywell2
Nice chart.freddie ferret
Not the Antisoma we once knew, gamboling by George! Mind you there is money in gamboling!freddie ferret
Yippeee 2pjsbach123
20 December 2012 Antisoma plc ("Antisoma") Agreement with GVC Holdings plc ("GVC") The Directors announce that on 20 December 2012, Antisoma entered into an agreement to subscribe, as described below, up to GBP4.0 million of new ordinary shares proposed to be issued by GVC in connection with its recommended offer, together with William Hill Australia Pty Limited ("William Hill"), for Sportingbet plc ("Sportingbet") (the "Offer"), which was announced today. GVC has offered as consideration, for the businesses of Sportingbet which it proposes to acquire and retain, 29.0 million new GVC ordinary shares with a value of approximately GBP67.7 million at 233.5p per share, being the closing price on 15 October 2012, the last business day prior to the suspension of trading in GVC shares. Sportingbet shareholders are also being offered cash financed through a payment by William Hill in relation to the businesses of Sportingbet to be transferred to William Hill. As part of the GVC shares consideration, Sportingbet shareholders are being offered the opportunity to accept either these new GVC ordinary shares or a cash alternative of 233.5p per share. To the extent that a mix and match arrangement does not operate so as to deliver to any eligible Sportingbet shareholders the full amount of cash consideration for which they have elected, GVC has entered into a series of agreements whereby various parties have agreed to subscribe new GVC ordinary shares to underpin the cash consideration elected for by Sportingbet shareholders. Antisoma has entered into such an agreement with GVC to subscribe up to 1,713,062 new GVC ordinary shares at 233.5p per share, which represents a total potential commitment of GBP4.0 million. 1,713,062 new GVC ordinary shares would represent approximately 2.8 per cent. of GVC's issued ordinary share capital assuming full acceptance of the Offer. As consideration for this commitment, Antisoma has been granted subscription options over a further 343,053 new GVC ordinary shares, which are exercisable at 233.5p per share until the third anniversary from the date of grant. Antisoma's commitment continues until the earlier of the date on which the Offer is declared wholly unconditional or 30 June 2013. Antisoma will make a further announcement as soon as possible thereafter as to the number of new GVC ordinary shares subscribed under this agreement. In the 6 months ended 30 June 2012, GVC made a profit before taxation of Euro 5.2 million on revenue of Euro 29.1 million (Year ended 31 December 2011, loss before tax of Euro 0.14 million on revenue of Euro 44.34 million). Its net assets at 30 June 2012 amounted to Euro 57.98 million. Further information on the Offer, GVC and Sportingbet is set out in the announcement of the Offer of today's date. Contacts: Antisoma plcleedskier
nice up channel since august. is anybody out there ?mrsapeslaptop
Hello....??? Up 12% today..........palwing8
Another month passes with no news at all. Great work if you can get it.jsbach123
I would be happy if they used all of the cash to buy shares in Scancell Holdingsred army
I think it is a not unreasonable expectation from shareholders that such management that remain and draw salaries from company funds could issue some sort of news statement, or turn the company into a closed tracker fund (or better still wind the company up and return what little remains to shareholders).jsbach123
Spending money on directors remuneration..fenners66
Anybody know what on earth Antisoma are doing now?dbharrison1
There are convincing arguments that when a company clearly has failed but still has some assets to wind it up and return whatever value there is left to shareholders. Or if that is too complex and majority shraeholders are desperate to keep it trading perhaps ASM should reinvent itself as a tracker fund - more profitable probably johnsmith than the 'range of smaller investments' you envisage.jsbach123
john smith - I wasnt referring to salariesthe_doctor
Hi the-doctor, Everyone except 4 directors have been fired in antisoma. Directors salaries have been slashed to 29000, 30000, 3000 and 1 unknown (new director Ross Hollyman). Therefore, money drain has stopped and should be covered from interest of money in the bank and remaining 1mil annual payments for the drug they previously sold off. They also have some large tax offset available to them due to previous R&D activity. All money will now be invested in to a range of smaller investments (probably non-pharmaceutical) rather than 1 or 2 high risk drugs (Avg. 70% failure rate per drug). The future looks bright,johnsmith321
Chat Pages: 424  423  422  421  420  419  418  417  416  415  414  413  >>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 151201 18:16